Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellular Biomedicine Group Inc (NASDAQ:CBMG)

17.80
Delayed Data
As of Feb 05
 -0.70 / -3.78%
Today’s Change
10.44
Today|||52-Week Range
49.00
-17.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues35.5K9.4M4.1M564.4K
 
 
 
 
 
Cost of Goods Sold0.000.00763.5K213.2K
 
 
 
Depreciation And Amortization0.000.00841.2K1.2M
 
 
 
 
Operating ExpensesGross Income35.5K9.4M2.5M-839.4K
 
 
 
 
 
General Expenses1.3M1.5M11.3M10.2M
 
 
 
 
 
Research And Development0.00--1.9M2.7M
 
 
 
Total Operating Expenses1.3M1.5M12.9M11.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.3M7.9M-8.9M-11.0M
 
 
 
 
 
Extraordinary Credit0.006.1K0.00--
 
 
Extraordinary Charge0.000.00-4.3M-1.4M
 
 
 
Interest Expense On Debt9.9K58.00257.8K0.00
 
 
 
 
Other Expenses477.6K1.4M-71.5K72.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-766.4K9.3M-13.5M-12.4M
 
 
 
 
 
Income Taxes0.00-86.8K-344.4K0.00
 
 
 
Discontinued Operations0.000.000.00-3.1M
 
 
Net Income-766.4K9.2M-13.8M-15.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M1.6M5.8M8.6M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M1.6M5.8M8.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00$591.00-$2.38-$1.79
 
 
 
 
 
EPS Diluted-$1.00$6.00-$2.38-$1.79